Tuesday, November 17, 2026
Late edition · Updated as it breaks
Log inSubmit a story

“All the news worth catching.”

PaparazziPaparazzi
How to earnPaparazzi InkBack PageHolder perksLeaderboardAssignmentsContestsLeagueCity
Catcher tip lineCaught a story first? Earn stock tokens →
Sponsored
Premium projects
DEDeFadePAPackedYour project here
PaparazziPaparazzi

All the news worth catching.

Breaking news on tech, crypto, EVs, e-commerce and social the moment it breaks. Written by AI from verified reporting.

SectionsTop storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & world
EarnStart hereSubmit a storyHow to earnLeaderboardContestsCatcher desksTop catchers by reputationAssignmentsCity LeagueNews bountiesCityMy catchesRewards
MarketsLive statsProof of payoutsWhale watchDeep Scan token checksStock fundToken utilityRobinhood Chain launchesRobinhood Chain projectsPremium project pagesPartnersThe Chain Weekly
PaparazziPaparazzi InkPaparazzi Ink top writersThe Back PageSuggest a Back Page storyPaparazzi on TelegramHow it worksFAQProof of workAbout usHow we score trustEditorial policyPrivacy policyCorrectionsRelease notesAdvertiseContact
$PAPA contract · Robinhood Chain
© 2026 Paparazzi

Written by AI from verified reporting. Not financial advice.

  • Home
  • Submit
  • Earn
  • Sign in
Top storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & worldWhales
Health & science
Minor· 25

RNA dimmer switch helps mice survive lethal sepsis, study finds

UC Santa Cruz researchers found Gaplinc, a long noncoding RNA, works like a dimmer switch inside immune cells, tuning both inflammation and metabolism. Mice stripped of it survived lethal doses of bacterial toxin that killed normal mice. The team says targeting it could give doctors a new way to treat sepsis, a disease with few options beyond fluids and antibiotics.

By the Paparazzi desk Caught by @lantern129
Networker · Silver
November 17, 2026 · 1:40 PM · medicalxpress.com · 0 views
Fact boxTrust 40/100 · Unverified
What we verified
  • Original source: medicalxpress.com.
  • The source published it on Nov 17, 2026 at 1:40 PM.
What we couldn't
  • Not verified by major outlets. This story may be false.
  • No second outlet has reported it yet. Treat it as a single-source claim.

The mechanism is a long noncoding RNA called Gaplinc, which lives in macrophages — the immune cells that sound the alarm during infection. According to the UC Santa Cruz team behind the work, Gaplinc latches onto an enzyme named MCCC1 inside mitochondria, the cell's energy factories, effectively wiring gene expression to metabolic processing. When the researchers deleted the molecule entirely in mice, baseline immune genes sat slightly 'pre-armed' and circulating blood fats tipped into a protective, sepsis-resistant balance.

The payoff was stark: every Gaplinc-deficient mouse survived lethal levels of bacterial toxin that proved fatal to normal mice. Losing the RNA boosted helpful lipids called lysophosphatidylcholines and pared back toxic free fatty acids. Push Gaplinc too far the other way — overproducing it — and baseline immune readiness sank so low the animals became far more vulnerable to swift, fatal shock. It behaves as a rheostat, not an on-off switch.

Sponsored

The stakes are enormous. Sepsis kills at least 20% of adults and 10% of children who develop it, according to the CDC, and the agency counts it in one out of every three hospital deaths nationwide. The condition is behind at least 350,000 adult deaths and more than 1,800 child deaths each year during hospitalization or after transfer to hospice. Clinicians today have little beyond fluids, antibiotics and supportive care once runaway inflammation starts damaging healthy organs.

Senior author Susan Carpenter, a professor of molecular, cell and developmental biology at UC Santa Cruz and co-director of the UCSC RNA Center, framed the appeal of a gentler approach. 'Sepsis is devastating because once that inflammatory cascade spirals out of control, clinicians mostly have to rely on supportive care and hope the patient can weather the storm,' she said. Rather than shutting the immune system down and leaving patients exposed to the underlying infection, she said, 'targeting Gaplinc could let us fine-tune the body's metabolic resilience to survive the shock.'

The work, a collaboration published in the Proceedings of the National Academy of Sciences, points toward transient RNA therapeutics — lipid nanoparticles, for instance — that could temporarily rebalance Gaplinc levels and reprogram metabolism during an acute infection. Carpenter's lab first found that the RNA regulates key inflammatory genes driven by a specific protein complex; the new paper, she said, 'expands this foundation by demonstrating how Gaplinc operates across systemic organ networks and metabolic pathways.'

TopicsGaplinc · UC Santa Cruz · Susan Carpenter · MCCC1 · Proceedings of the National Academy of Sciences · CDC · UCSC RNA Center · lipid nanoparticles

Share

Source: medicalxpress.com

Written by AI from verified reporting.

More stories

  • Health & science 33 minutes ago · scitechdaily.com · 0 views
    FDA Clears Teplizumab for Kids Newly Diagnosed With Type 1 Diabetes
  • Health & science 4 hours ago · inquirer.com · Caught by @Midas👑 · 0 views
    CDC Study Finds 112 Pregnant Women and 13 Newborns Sickened by Measles
  • Health & science 7 hours ago · theguardian.com · 0 views
    European Pesticides Named in 1,605 Brazil Poisoning Reports
  • Health & science 8 hours ago · theepochtimes.com · 0 views
    FDA Refuses to Approve Akeso-Summit Lung Cancer Drug After Survival Miss
Catcher tip line

Caught a story we missed?

Log in and send it in. If it checks out, it runs with your name on it and you earn stock tokens. The bigger the story, the bigger the reward.

Submit a story
The newsletter

Get the paper in your inbox.

A short digest of the biggest news, plus optional breaking alerts. Free, no account needed.